THE USE OF BETA-BLOCKER BISOPROLOL FOR THE PREVENTION OF HIGH BLOOD PRESSURE IN WOMEN WITH IDIOPATHIC ARTERIAL HYPOTENSION

This study is devoted to the problem of arterial hypertension (AH), developing with age in women with idiopathic arterial hypotension (IAH).In the survey of 650 women doctors revealed the high frequency of AHI (up to 24,8% ), accompanied by every second or third case of periodic increase in blood pressure with clinical vascular symptoms. An important role in the prevention of hypertension on the background of IAG given to therapy with beta blockers, in particular, bisoprolol. Conducted in 27 women daily monitoring of blood pressure showed that, to revent the increase in BP in the background of the IAG, it is advisable to choose the starting dose of bisoprolol 2.5 mg, increasing it as needed under the control of blood pressure, heart rate and clinical symptoms. The most pronounced hemodynamic changes have occurred in patients receiving bisoprolol dose of 5 mg. however, almost a threefold increase in episodes of hypotension (hypotonic index) and is probably associated with increasing variability of systolic, AP, was regarded as unwanted excessive effect of the drug. Reducing the dosage of bisoprolol to 2.5 mg/day was accompanied by an almost threefold decrease in hypotonic
index and two-time decrease in BP variability. These changes occurred against the backdrop of milder antihypertensive effects and pulseraduction without any negative influence on positive clinical dynamics. . A reduction in the dose of bisoprolol during the titration of therapeutic effect lowered the risk of side reactions and improves the adherence of women with labile AD to treatment.

1. Owens P, O’Brien E. Hypotension; A forgotten Illness? Blood Press Monitor 1996 ; 2: 3-14

2. Савенков М.П., Иванов С.Н., Штандель Л.Н., Савенкова А.М., Постникова З.В. Возрастные аспекты дозирования бета-адреноблокторов при лечении АГ на примере применения бисопролола. Consilium medicum 2016; 18(1); 21-24/ M.P. Savenkov, S.N. Ivanov, L.N. Shtandel, A.M. Savenkova, Z.V. Postnikova. Age aspects of beta-adrenergic blocking agents at therapy of arterial hypotension by the example of bisoprolol use. Consilium medicum 2016, Vol. 18 (1): p. 21-24.

3. Чефранова Ж.Ю. Идиопатическая артериальная гипотензия. Клиника, диагностика, лечение. М.: Медицина, 2005. /Chefranova Z.Y. Idiopathic arterial hypotension. Clinics, diagnostics, therapy. M.: Meditsina. 2005.

4. Вейн A.M. Вегетативные расстройства: Клиника, лечение, диагностика. М.: МИА, 2002/Wein A.M. Vegetative disturbances: Clinics, therapy, diagnostics. M.: MIA, 2002.

5. Owens Р., Lyons S., and O’Brien E. Arterial hypotension: prevalence of low blood pressure in the general population using ambulatory blood pressure monitoring. J.Hum. Hypertens. 2000;14(4):243-7

6. Документ о соглашении экспертов по блокаторам β-адренерги ческих рецепторов. Рабочая группа Европейского общества кардиологов по бета-блокаторам // Кардиоваскулярная терапия и профилактика. 2005. № 1. 99–12. /Document on agreement of experts on β-adrenergic blocking agent receptors. Working group of the Cardiologist European Association on Beta-Adrenergic Blocking Agents// Kardiovaskulyarnaya

7. Terapiya I Profilaktika. 2005. No.1. 99–12.